PARIS] Ozempic-maker Novo Nordisk is planning to make more of its medicines for the US market in the country; Boeing risks a gummed up supply chain and higher aircraft costs it may not be able to pass ...

A look at the day ahead in European and global markets from Kevin Buckland Wall Street's mild bounce on the back of a tame ...

Investors, financial advisors Tracking the stock market with new tariffs being implemented and ongoing trade disputes with ...